Develops non-invasive ultrasound devices for prostate cancer treatment.
Dec 2025Revenue $70.5M/yrExpenses $95.2M/yr
No trendCash runway ≈ 1.7 years from Jun 2026
Figures by year
When will Edap TMS be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $70.5M and expenses $95.2M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $70.5M | $95.2M | −$24.7M |
| Dec 2024 | $69.4M | $91.6M | −$22.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.